Pegenzileukin, a Selectively Pegylated IL-2 Analog, Enhances Anti-Tumor Function of NK Cells without Activating Regulatory T Cells

被引:0
|
作者
Oja, Anna [1 ]
Kasic, Nada-Katarina [1 ]
Cesonyte, Ieva [1 ]
Franciszkiewicz, Katarzyna [2 ]
Calvet, Loreley [2 ]
Sidhu, Sukhvinder [2 ]
Kunert, Andre [1 ]
Igarashi, Robert [1 ]
机构
[1] Sanofi, Oncol Res, Amsterdam, Netherlands
[2] Sanofi, Oncol Res, Vitry Sur Seine, France
关键词
D O I
暂无
中图分类号
Q81 [生物工程学(生物技术)]; Q93 [微生物学];
学科分类号
071005 ; 0836 ; 090102 ; 100705 ;
摘要
1776
引用
收藏
页码:828 / 828
页数:1
相关论文
共 50 条
  • [31] Potential anti-tumor effects of regulatory T cells in the tumor microenvironment: a review
    Yu Li
    Cangang Zhang
    Aimin Jiang
    Anqi Lin
    Zaoqu Liu
    Xiangshu Cheng
    Wanting Wang
    Quan Cheng
    Jian Zhang
    Ting Wei
    Peng Luo
    Journal of Translational Medicine, 22
  • [32] The natural product chitosan enhances the anti-tumor activity of natural killer cells by activating dendritic cells
    Li, Xinxin
    Dong, Wenjuan
    Nalin, Ansel P.
    Wang, Yufeng
    Pan, Pan
    Xu, Bo
    Zhang, Yibo
    Tun, Steven
    Zhang, Jianying
    Wang, Li-Shu
    He, Xiaoming
    Caligiuri, Michael A.
    Yu, Jianhua
    ONCOIMMUNOLOGY, 2018, 7 (06):
  • [33] Identification of PP2A as an intrinsic checkpoint of T-bet and anti-tumor effector function of NK cells
    Yamamae, Yui
    Kawada, Manabu
    Hayakawa, Yoshihiro
    CANCER SCIENCE, 2023, 114 : 814 - 814
  • [34] Radiotherapy enhances the anti-tumor effect of CAR-NK cells for hepatocellular carcinoma
    Lin, Xiaotong
    Liu, Zishen
    Dong, Xin
    Wang, Kunyuan
    Sun, Yao
    Zhang, Han
    Wang, Fei
    Chen, Ying
    Ling, Jing
    Guo, Yuetong
    Xiang, Hongjin
    Xie, Qiankun
    Zhang, Yuqin
    Guo, Zhaoze
    Sugimura, Ryohichi
    Xie, Guozhu
    JOURNAL OF TRANSLATIONAL MEDICINE, 2024, 22 (01)
  • [35] PD-L1 blockade enhances anti-tumor efficacy of NK cells
    Oyer, Jeremiah L.
    Gitto, Sarah B.
    Altomare, Deborah A.
    Copik, Alicja J.
    ONCOIMMUNOLOGY, 2018, 7 (11):
  • [36] Identification of PP2A as an intrinsic checkpoint of T-bet and anti-tumor effector function of NK cells
    Yamamae, Yui
    Kawada, Manabu
    Hayakawa, Yoshihiro
    CANCER SCIENCE, 2023, 114 : 1165 - 1165
  • [37] Differential targeting of IL-2 and T cell receptor signaling pathways selectively expands regulatory T cells while inhibiting conventional T cells
    Satake, Atsushi
    Schmidt, Amanda M.
    Archambault, Angela
    Leichner, Theresa M.
    Wu, Gregory F.
    Kambayashi, Taku
    JOURNAL OF AUTOIMMUNITY, 2013, 44 : 13 - 20
  • [38] The Role of Regulatory T Cells in the Modulation of Anti-Tumor Immune Response
    Radosavljevic, Gordana D.
    Jovanovic, Ivan P.
    Kanjevac, Tatjana V.
    Arsenijevic, Nebojsa N.
    SRPSKI ARHIV ZA CELOKUPNO LEKARSTVO, 2013, 141 (3-4) : 262 - 267
  • [39] Anti-tumor immunity and autoimmunity: a balancing act of regulatory T cells
    Wei-Zen Wei
    Gerald P. Morris
    Yi-chi M. Kong
    Cancer Immunology, Immunotherapy, 2004, 53 : 73 - 78
  • [40] Regulatory T cells as suppressors of anti-tumor immunity: Role of metabolism
    De Rosa, Veronica
    Di Rella, Francesca
    Di Giacomo, Antonio
    Matarese, Giuseppe
    CYTOKINE & GROWTH FACTOR REVIEWS, 2017, 35 : 15 - 25